Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & Administrative
Others
Ratios

Bone Biologics (BBLGW) Shares Outstanding (Diluted Average) (2016 - 2017)

Bone Biologics (BBLGW) has disclosed Shares Outstanding (Diluted Average) for 2 consecutive years, with $4.1 million as the latest value for Q2 2017.